Me too

After next round of the bake-off, going to pivot to tumor antigens (once we get some mass spec validation of which ones are real).

For now, read the blog post by @benjamingvincent.bsky.social: pirlblog.substack.com/p/an-experim...

There will likely be a narrowing of lanes around tumor cell-specific targeting though, which you need for your pMHC binders, antibodies or similar, and nucleic acid therapies … same will be true of the cancer-eating nanobots in the further future …

Whoever gets the good training data first wins

Yes - it’s awesome how science builds on itself unexpectedly